Wai Chun Biotec lifts issued share capital by 6.52% via HK$1.35 million convertible-bond conversion

Bulletin Express

May 05

Wai Chun Bio-Technology Limited reported a 6.52% expansion in its issued share capital after converting HK$1.35 million of outstanding convertible bonds into equity on 05 May 2026.

The transaction resulted in the allotment and issuance of 22.50 million new ordinary shares at HK$0.01 each. Following the conversion, the company’s total number of issued shares (excluding treasury shares) increased to 367.64 million from 345.14 million as at 30 April 2026.

No treasury shares were created, redeemed or sold, and there were no on-market share repurchases or cancellations during the period under review.

The board confirmed that the share issuance complied with all relevant requirements of the Hong Kong Stock Exchange’s Main Board rules, and that all funds due from the conversion have been duly received.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1168382726"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1168382726\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1168382726?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168382726","market":"us","top_or_hot":-1,"title":"Wai Chun Biotec lifts issued share capital by 6.52% via HK$1.35 million convertible-bond conversion","media":"Bulletin Express","content":"<p>Wai Chun Bio-Technology Limited reported a 6.52% expansion in its issued share capital after converting HK$1.35 million of outstanding convertible bonds into equity on 05 May 2026.</p>\n<p>The transaction resulted in the allotment and issuance of 22.50 million new ordinary shares at HK$0.01 each. Following the conversion, the company’s total number of issued shares (excluding treasury shares) increased to 367.64 million from 345.14 million as at 30 April 2026.</p>\n<p>No treasury shares were created, redeemed or sold, and there were no on-market share repurchases or cancellations during the period under review.</p>\n<p>The board confirmed that the share issuance complied with all relevant requirements of the Hong Kong Stock Exchange’s Main Board rules, and that all funds due from the conversion have been duly received.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wai Chun Biotec lifts issued share capital by 6.52% via HK$1.35 million convertible-bond conversion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWai Chun Biotec lifts issued share capital by 6.52% via HK$1.35 million convertible-bond conversion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-05 18:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wai Chun Bio-Technology Limited reported a 6.52% expansion in its issued share capital after converting HK$1.35 million of outstanding convertible bonds into equity on 05 May 2026.</p>\n<p>The transaction resulted in the allotment and issuance of 22.50 million new ordinary shares at HK$0.01 each. Following the conversion, the company’s total number of issued shares (excluding treasury shares) increased to 367.64 million from 345.14 million as at 30 April 2026.</p>\n<p>No treasury shares were created, redeemed or sold, and there were no on-market share repurchases or cancellations during the period under review.</p>\n<p>The board confirmed that the share issuance complied with all relevant requirements of the Hong Kong Stock Exchange’s Main Board rules, and that all funds due from the conversion have been duly received.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00660","symbol_name":"玮俊生物科技","start_time":0,"source_url":"","article_id":"1168382726","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168382726","pubTimestamp":1777977863,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Wai Chun Bio-Technology Limited reported a 6.52% expansion in its issued share capital after converting HK$1.35 million of outstanding convertible bonds into equity on 05 May 2026. The transaction...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00660":"玮俊生物科技"},"translate_title":"伟俊生物科技透过135万港元可换股债券转换将已发行股本增加6.52%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00660":1},"content_text":"Wai Chun Bio-Technology Limited reported a 6.52% expansion in its issued share capital after converting HK$1.35 million of outstanding convertible bonds into equity on 05 May 2026.\nThe transaction resulted in the allotment and issuance of 22.50 million new ordinary shares at HK$0.01 each. Following the conversion, the company’s total number of issued shares (excluding treasury shares) increased to 367.64 million from 345.14 million as at 30 April 2026.\nNo treasury shares were created, redeemed or sold, and there were no on-market share repurchases or cancellations during the period under review.\nThe board confirmed that the share issuance complied with all relevant requirements of the Hong Kong Stock Exchange’s Main Board rules, and that all funds due from the conversion have been duly received.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}